528 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Strategic Financial Concepts LLC

Strategic Financial Concepts LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 528 shares of the healthcare conglomerate’s stock, valued at approximately $261,000.

Other institutional investors have also added to or reduced their stakes in the company. Bray Capital Advisors boosted its holdings in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after buying an additional 50 shares in the last quarter. Asset Management One Co. Ltd. boosted its holdings in UnitedHealth Group by 0.5% in the third quarter. Asset Management One Co. Ltd. now owns 479,578 shares of the healthcare conglomerate’s stock worth $241,798,000 after acquiring an additional 2,245 shares in the last quarter. Warren Street Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 10.3% during the third quarter. Warren Street Wealth Advisors LLC now owns 783 shares of the healthcare conglomerate’s stock valued at $395,000 after acquiring an additional 73 shares in the last quarter. Blue Fin Capital Inc. grew its position in UnitedHealth Group by 1.6% during the 3rd quarter. Blue Fin Capital Inc. now owns 14,861 shares of the healthcare conglomerate’s stock valued at $7,493,000 after purchasing an additional 234 shares during the last quarter. Finally, WestEnd Advisors LLC lifted its holdings in shares of UnitedHealth Group by 9.6% during the third quarter. WestEnd Advisors LLC now owns 72,726 shares of the healthcare conglomerate’s stock valued at $36,668,000 after purchasing an additional 6,360 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research note on Thursday, April 4th. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Down 1.1 %

Shares of NYSE:UNH traded down $5.33 during mid-day trading on Tuesday, reaching $483.70. 3,366,904 shares of the company were exchanged, compared to its average volume of 4,466,545. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The firm’s 50-day simple moving average is $484.44 and its 200 day simple moving average is $513.42. The firm has a market cap of $445.04 billion, a price-to-earnings ratio of 29.57, a P/E/G ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.